A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

NCT04322292 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: C-CAR088

Sponsor

Institute of Hematology & Blood Diseases Hospital, China